Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L17 pseudogene 39 (RPL17P39) is a processed pseudogene in the human genome, meaning it is a non-coding DNA segment derived from the functional RPL17 gene. Although this locus retains an open reading frame similar to the original gene, it is not transcribed or translated into a functional ribosomal protein and does not participate in ribosome assembly or cellular protein synthesis. As with many ribosomal protein pseudogenes, RPL17P39 exists due to retrotransposition events and serves no known biological function. It is not considered a therapeutic target. Documentation and databases denote it simply as a pseudogene, and there is no indication of druggability, disease association, nor use as a biomarker in research or clinical practice[5][9][10][11]. Key points: - This entry is a pseudogene and not a functional protein-coding gene. - It is not involved in known biological functions or disease processes. - There are no drugs or mechanisms targeting this pseudogene. - The entry is not suitable as a therapeutic target and often appears in scientific databases for genomic annotation purposes only[5][10]. Related but distinct: - The functional gene RPL17 encodes a component of the 60S ribosomal subunit and has biological relevance, but RPL17P39 does not share these properties[8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L17 pseudogene 39 (RPL17P39).